⌘K

Login Start Free

Home/Filings/4/0001104659-21-092103

4//SEC Filing

Judy Chou 4

Accession 0001104659-21-092103

CIK 0001744659other

View on SEC.gov Company Profile

Filed

Jul 13, 8:00 PM ET

Accepted

Jul 14, 4:09 PM ET

Size

5.3 KB

Accession

0001104659-21-092103

Insider Transaction Report

Form 4

Period: 2021-07-12

Akero Therapeutics, Inc.AKRO

Director

Transactions

Award
Stock Option (Right to Buy)
2021-07-12−26,000→ 26,000 total
Exercise: $24.87Exp: 2031-07-12→ Common Stock (26,000 underlying)

Footnotes (1)

[F1]This option shall vest and become exercisable in 36 equal monthly installments, commencing on July 12, 2021.

Documents

1 file

4
tm2122186-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Akero Therapeutics, Inc.

CIK 0001744659

Entity typeother

Related Parties

1

filerCIK 0001871695

Filing Metadata

Form type: 4
Filed: Jul 13, 8:00 PM ET
Accepted: Jul 14, 4:09 PM ET
Size: 5.3 KB

View on SEC.gov